Enabling Capabilities and Solutions for all mRNA (Nucleic Acid) platforms - Process Development, Manufacturing and Formulation

BPI Contributor

September 12, 2022

1 Min Read
Enabling Capabilities and Solutions for all mRNA (Nucleic Acid) platforms - Process Development, Manufacturing and Formulation

Conquer the mRNA era. Advancing together from initial idea to final product.

Your molecule’s journey to the market is a long and complex one. You need an experienced and trustworthy partner who understands the varying challenges you face and helps you solve them efficiently, safely and speedily. No matter whether you’re still in the idea stage, ready to scale up your production or need specific regulatory know-how for a successful launch of your mRNA drug. From mRNA development and manufacturing to fill finish of the final formulation, discover MilliporeSigma’s integrated offering of an extensive portfolio of products, a wide range of services, CDMO capabilities, regulatory and technical expertise.

Explore here our full process flow for mRNA manufacturing and formulation that will increase efficiency, accelerate timelines, and adapt to any scale. From plasmid production to final fill and finish: you will discover how our regulatory know-how, integrated portfolio of products and services, and applications expertise can help you overcome your mRNA process challenges with a simple and robust platform.


You May Also Like